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Background: The aim of this study was to develop and evaluate psychometric properties of the Clinical Decision
Making Style (CDMS) scale which measures general preferences for decision making as well as preferences
regarding the provision of information to the patient from the perspectives of people with severe mental illness
and staff.
Methods: A participatory approach was chosen for instrument development which followed 10 sequential steps
proposed in a current guideline of good practice for the translation and cultural adaptation of measures. Following
item analysis, reliability, validity, and long-term stability of the CDMS were examined using Spearman correlations in
a sample of 588 people with severe mental illness and 213 mental health professionals in 6 European countries
(Germany, UK, Italy, Denmark, Hungary, and Switzerland).
Results: In both patient and staff versions, the two CDMS subscales “Participation in Decision Making” and
“Information” reliably measure distinct characteristics of decision making. Validity could be demonstrated to some
extent, but needs further investigation.
Conclusions: Together with two other five-language patient- and staff-rated measures developed in the CEDAR
study (ISRCTN75841675) – “Clinical Decision Making in Routine Care” and “Clinical Decision Making Involvement and
Satisfaction” – the CDMS allows empirical investigation of the complex relation between clinical decision making
and outcome in the treatment of people with severe mental illness across Europe.Background
Decision-making in health care has been conceptualized
as a process taking place between patient and health
professional on a continuum between “paternalistic”,
“shared”, and “informed” [1,2]. Shared decision making
has received much attention in research and practice
since its first mention 30 years ago [3]. Substantial* Correspondence: bernd.puschner@bkh-guenzburg.de
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reproduction in any medium, provided the orevidence has accumulated in recent decades for clinical
decision making in acute (e.g. heart attack, stroke) and
long-term physical conditions (e.g. cancer and fibro-
myalgia) [4-10]. Shared decision making has been
termed an ethical imperative [11] and is recommended
in guidelines for the treatment of people with schizo-
phrenia [12].
However, knowledge about clinical decision making in
the treatment of people with mental illness is still lim-
ited. Most importantly, apart from a few studies [13], lit-
tle is known about the relation between clinical decisional Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Knowledge gaps relating to investigating this link have
been identified, including: (a) descriptive research and
instrument development focussing on how decisions are
actually made in routine care; (b) the development of
measures to characterize decision making processes, es-
pecially in people with long-term mental disorder; and
(c) the measurement of both patients’ and professionals’
decision making styles and how these are enacted in de-
cision making encounters [14-16].
Published scales measuring decision making have been
summarised in four recent reviews; three with a focus
on shared decision making [16-19] and one specifically
examining professionals’ perceptions of decision making
[20]. Scales identified in these reviews measured a wide
range of aspects of clinical decision making, which were
thematically grouped by the authors of these reviews:
“decision making needs”, “decision support”, and “evalu-
ation of process and outcome” by Simon and colleagues
[17]; “values and preferences”, “information and commu-
nication”, and “other” by Dy [18]; and “antecedents”,
“process” and “outcomes” by Scholl and colleagues [19].
However, psychometric properties of most measures,
especially validity, have not yet been sufficiently demon-
strated [17,19]. Furthermore, many instruments assess
preferences at a high level of abstraction, while little is
known about actual decision behaviour in routine care
[18]. Moreover, by exclusively assessing decision making
from the perspective of the patient, instrument develop-
ment has largely ignored reciprocity as a defining feature
of decision making [1,21-23]. For example, even though
some instruments to assess decision making from the
perspective of health professionals have been developed
[20], there is a lack of parallel versions with an explicit
focus on the reciprocal assessment of decision making
[17,19] from both patient and professional perspectives.
With a few exceptions (e.g. [24]), instruments used to
assess decision making in the treatment of people with
mental illness have been developed in samples of people
with physical conditions (mainly cancer). However, there
is emerging evidence that psychometric properties of de-
cision making measures substantially vary by illness and
treatment variables [25]. Thus, untested use of an instru-
ment in populations other than the original target sam-
ple may be problematic. Nevertheless, some scales
developed for other conditions have been successfully
validated for assessing decision making in the treatment
of people with mental illness, e.g. [26,27]. Notably the
“Autonomy Preference Index” (API) [28] consisting of
two subscales (15 item “decision-making preferences”
and 8-item “information-seeking preferences”) has been
widely used in mental health research [29-31]. Internal
consistency (Cronbach’s α) of the original version [28]
examined in 312 general medicine patients was .82 forboth subscales, and test-retest reliability after two weeks
in a subsample (N = 50) was .84 for the decision making
preferences subscale, and .83 for the information seeking
preferences subscale. For an abridged version of the API
decision-making preferences subscale (6 items), a Ger-
man study reported internal consistencies (Cronbach’s α)
of .79 for GP patients with depression(N = 230), and of
.59 for psychiatric inpatients with schizophrenia (N = 120)
[32]. In a confirmatory factor analysis, three items
showed questionable reliability in a sample of 1,592
patients with various conditions including 186 people
with depression [33].
In order to measure key aspects of clinical decision
making in the routine care for people with severe mental
illness, the CEDAR study developed patient and staff
versions of three new instruments, to measure: clinical
decision making style; key elements of clinical decision
making in routine care; and clinical decision making in-
volvement and satisfaction.
This paper reports on the development and translation of
the Clinical Decision Making Style Scale (CDMS), and inves-
tigates its psychometric properties (internal consistency, val-
idity, and test-retest reliability) in a sample of 588 people
with severe mental illness and 213 mental health profes-
sionals from six European countries. The development and
psychometric properties of the Clinical Decision Making
Involvement and Satisfaction Scale (CDIS) and the Clinical
Decision Making in Routine Care Scale (CDRC) are
reported elsewhere [34,35].
Methods
Instrument development
Development of the Clinical Decision Making Style Scale
(CDMS) followed the International Society for Pharma-
coeconomics and Outcomes Research (ISPOR) Task
Force principles of good practice for the translation and
cultural adaptation of patient-reported outcome mea-
sures [36]. The ISPOR Framework identifies ten sequential
steps: 1 preparation; 2 forward translation; 3 reconciliation;
4 back translation; 5 back translation review; 6 harmonisa-
tion; 7 cognitive debriefing; 8 review of cognitive debriefing
results and finalisation; 9 proof-reading; and 10 final
report. We refer to these steps as ISPOR 1 to ISPOR
10 respectively.
Focus groups were held in ISPOR 1 and 7. Focus
groups are widely used to examine people’s experience
with illness and health services. They especially aim at
enabling vulnerable people to freely express their views
in the format of a moderated group discussion [37-39].
Patient participants of focus groups were convenience
samples of native speaker adults aged 18-60 using local
non-forensic mental health services. Staff participants
were workers in these services. Focus groups were held
in non-clinical settings, and moderated and co-
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that all responders had sufficient opportunity to air their
views and that non-verbal group dynamics were noted.
All focus groups were audiotaped and fully transcribed.
Development of the source language CDMS (ISPOR 1)
At the first CEDAR study meeting in May 2009, Ulm re-
search workers presented results of an extensive litera-
ture search on the instruments with a special focus on
identifying scales to be considered candidates for inclu-
sion. Presentations were discussed by the study group
including advisory board member, which informed the
drafting of a topic guide for the first round of focus
groups. Subsequently, six focus groups (4 with 23
patients altogether, 2 with 8 clinicians altogether) were
held by researchers in Ulm to explore the conceptual
understanding of clinical decision-making. Topics cov-
ered included the experience of making decisions as well
as level of involvement and satisfaction with the process
during the last treatment session. Procedures and results
of these focus groups have been reported in detail else-
where [40]. Subsequently the patient-rated “Autonomy
Preference Index” (API) [28] was chosen as the basis of
the CDMS, from which the Ulm study team produced a
parallel staff version. Both versions were in English. Per-
mission to use the instrument was granted by the author
of the API (J. Ende).
Development of the target language CDMS (ISPOR 2-10)
The API was forward translated from English into the
four other study languages (German, Italian, Hungarian,
and Danish; Switzerland used the German version)
(ISPOR 2). Forward translations in each centre were
done by native speakers of the target language who were
familiar with the concepts of the instrument. Assistance
from professional translators was drawn upon as needed,
and where more than one forward translations was pro-
duced independently of one another at a study centre,
these were compared and merged into one single for-
ward translation (ISPOR 3). Subsequently, in each study
centre one person fluent in the source language who had
not been involved into the forward translation(s) carried
out a blind (without seeing the source) back translation
into the source language (ISPOR 4). Back translations
were then compared to the original by CEDAR team
members who were English native speakers (ISPOR 5),
and potential discrepancies were discussed with the key
in-country person and corrected as needed (ISPOR 6).
Patient and staff versions of instrument drafts were then
subjected to a total of 17 focus groups (9 with 33
patients altogether, and 8 with 31 key workers
altogether) at all study sites in order to test alternative
wording and to check understandability, interpretation,
feasibility, and cultural relevance of the translations(ISPOR 7). Review of cognitive debriefing results based
upon reports of previous step to the Ulm study centre
resulted in some final amendments including changes in
text and omission of some items in order to arrive at
short and understandable measures. These changes
were: (i) omission of three items relating to information-
seeking (“You should understand completely what is
happening inside your body as a result of your illness”;
“Even if the news is bad, you should be well informed”;
“Information about your illness is as important to you as
treatment”); (ii) some changes in wording (e.g. “clinician”
instead of “doctor”, “I” instead of “you”); (iii) replace-
ment of the content of the three clinical vignettes which
in the original API relate to physical conditions (upper
respiratory tract illness, hypertension, and myocardial in-
farction) by vignettes relevant to people with mental ill-
ness (work, side effects, and medication); and (iv) to
achieve conceptual equivalence and logical consistency
between the parallel patient and staff versions, staff ver-
sion wording of items scores in section B and item con-
tent was adapted (ISPOR 8). Final versions were then
carefully proofread by local CEDAR team members and
checked for consistency in order of items and format by
the Ulm study team (ISPOR 9). This paper comprises
the final report of the entire process of instrument de-
velopment (ISPOR 10).
Psychometric evaluation
Following its development, the reliability and validity of
the CDMS was examined using data from the study
“Clinical Decision Making and Outcome in Routine Care
for People with Severe Mental Illness” (CEDAR;
ISRCTN75841675). Between November 2009 and De-
cember 2010, 588 people with severe mental illness gave
informed consent to participate in the CEDAR study
which is a naturalistic prospective longitudinal observa-
tional study with bimonthly assessments during a 12-
month observation period (T0-T6). Participants were
recruited from the caseloads of outpatient/community
mental health services at six centres throughout Europe:
Department of Psychiatry II, Ulm University, Germany
(coordinating centre); South London and Maudsley NHS
Foundation Trust, London, U.K.; the Department of
Psychiatry at Second University of Naples, Italy; the De-
partment of Psychiatry at Debrecen University, Hungary;
the Unit for Psychiatric Research at Aalborg Psychiatric
Hospital, Denmark; and the Department of General and
Social Psychiatry at University of Zurich, Switzerland.
Before the start of recruitment, the study protocol was
approved by ethics committees in all centres: Ulm Uni-
versity Ethics Commission; Joint South London and
Maudsley and Institute of Psychiatry Research Ethics
Committee; Ethical Committee of the Second University
of Naples, Naples; National Committee on Health
Puschner et al. BMC Psychiatry 2013, 13:48 Page 4 of 10
http://www.biomedcentral.com/1471-244X/13/48Research Ethics, North Denmark Region; Regional and
Institutional Ethics Committee, University of Debrecen
Medical and Health Science Center; and Kantonale
Ethikkommission Zürich. Inclusion criteria were: adult
age (18-60 years) at intake, mental disorder of any kind
as main diagnosis established by case notes or staff com-
munication using SCID criteria [41,42], presence of se-
vere mental illness (Threshold Assessment Grid [43] ≥ 5
points and illness duration ≥ 2 years); expected contact
with mental health services (excluding inpatient services)
during the time of study participation; sufficient com-
mand of the host country’s language; and capability of
giving informed consent. Exclusion criteria were: main
diagnosis of learning disability, dementia, substance use
or organic brain disorder; cognitive impairment severe
enough to make it impossible to give meaningful infor-
mation on study measures; and treatment by forensic
mental health services. Staff were recruited via patients
who identified a key professional at baseline. Data were
collected using questionnaires (filled in by the patient or
his or her key worker) or through interviews conducted
by the CEDAR research workers. Data entry modes were
via computer or paper-pencil forms. See Puschner et al.
[16] for further details on rationale and design of the
CEDAR study.
Measures
The CDMS is a modified version of the “Autonomy Pre-
ference Index” [28] adapted for use in mental health care
(see above). Patient (CDMS-P) and staff (CDMS-S) ver-
sions both have 21 items in three sections: (A) 6 items
referring to general preferences regarding patient auton-
omy in decisions (items #1, #2, #3 and #5 are reversed);
(B) 9 items referring to decision making preferences in
three scenarios (3 per vignette); and (C) 6 items refer-
ring to desire for information (item #19 is reversed).
Items in sections A and C are each rated on a five-point
Likert scale from “strongly disagree” (0) to “strongly
agree” (4). Items in section B are scored from 4 (“Me”)
to 0 (“Clinician”) in CDMS-P, and from 4 (“Service
user”) to 0 (“Me”) in CDMS-S.
CDMS subscales are Participation in Decision Making
(PD) which consists of the prorated mean of items in
sections A and B (ranging 0-4, with a higher score indi-
cating a higher desire by the service user to be an active
participant in decision making), and Information (IN)
consisting of the prorated mean of items in sections C
(ranging 0-4, 0 with a higher score indicating a higher
desire by the service user to be provided with informa-
tion). CDMS total scores were prorated when at least
80% of the items making up a scale had been completed,
i.e. at least 12 items of the PD subscale, and at least 4
items of the IN subscale. Categorical sum scores were
formulated on the basis of utility where an emphasis wasplaced on separating categories according to clinical
meaningfulness. Categories for PD subscale were Passive
(<1.5), Shared (1.5-2.5) and Active (>2.5), and for IN
subscale were Low (<2.0), Moderate (2.0-3.0) and High
(>3.0). These categories distinguish groups by their or-
dinal nature but not by a specific value assigned to each
category. The CDMS patient and staff versions in all five
CEDAR study languages can be downloaded at www.
cedar-net.eu/instruments.
Two items from the “Clinical Decision Making In-
volvement and Satisfaction” scale (CDIS, [34]), compris-
ing level of involvement (five point scale from “I made
the final decision” through “My clinician and I shared
responsibility for making the best decision for me” to
“My clinician made the final decision”) and satisfaction
(“I am satisfied that I am adequately informed about the
issues important to the decision”; five point scale from
“strongly disagree” to “strongly agree”).
The Stages of Recovery Inventory (STORI) is a patient-
rated 30-item assessment resulting in allocation to one of
three stages of recovery (“Moratorium”, “Awareness/
Preparation”, and “Rebuilding/Growth”) [44,45].
Analysis
Distribution characteristics were examined by means of
item analysis (means, standard deviation, skewness, kur-
tosis, missing values) and Q-Q plots. The Q-Q plot is a
graphical method for comparing two distributions. Sub-
scale scores were plotted against a theoretical normal
distribution (also called normal probability plot) where
points should approximately form a straight line.
Reliability was examined by calculating internal
consistency (Cronbach’s alpha) including confidence
intervals to increase precision of estimates [46], and by
analysis of discriminability. Interpretation of Cronbach’s
alphas followed the recommendations of Nunnally [47]
(“reliabilities of 0.7 or higher will suffice”, p. 245) and
George and Mallery [48] (acceptable: > .7; good: > .8; ex-
cellent: > .9). Discriminatory power was investigated by
calculating the Corrected Item-Total Correlation (CITC)
which gives the correlation between a given item and
the sum score of the other items making up the scale.
CITCs above .30 are considered adequate [49].
Furthermore, the continuous as well as the utility
(categorised) CDMS total scores were analysed via
Spearman correlations to establish relations among
CDMS subscales, convergent validity (with two CDIS
items), concurrent validity (with STORI recovery stage)
and stability over one year.
Results
Sample
A total of 708 patients were screened for eligibility, of
whom 588 were included. Reasons for exclusions were
Table 2 Sociodemographic and professional
characteristics of staff participants (N=213)
Study centre
Ulm, n (%) 48 (22.54)
London, n (%) 38 (17.84)
Naples, n (%) 17 (7.98)
Debrecen, n (%) 8 (3.79)
Aalborg, n (%) 59 (27.69)
Zurich, n (%) 43 (20.19)
Gender; female, n (%) 128 (61.84)
Age; years, M (SD) 46.03 (10.47)
Profession
Psychiatrist, n (%) 75 (36.41)
Psychologist, n (%) 19 (9.22)
Social Worker, n (%) 11 (5.34)
Other, n (%) 101 (49.03)
Working in outpatient mental health services; years, M (SD) 9.41 (8.44)
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pate (n=78), and other reasons (n=3: one suicide, one
deceased, one too anxious to participate). Patient partici-
pants are described in Table 1. Mean GAF score for par-
ticipants indicates serious symptomatology and social
disability, indicating that the TAG threshold had suc-
cessfully resulted in a sample of participants who can be
characterised as having severe mental illness.
Participating staff were in their mid-40s on average,
and mean time of working in mental health services was
15 years. The “other” category for professions included
nurse, district nurse, support time and recovery worker,
and psychiatric trainee (see Table 2).
Item characteristics and reliability
Patient version
As shown in Table 3 (left section), range of all items of the
CDMS-P PD was quite homogenous (SD = 0.89 – 1.36).
Items with the most extreme difficulties were #4 and #5,Table 1 Sociodemographic and clinical characteristics of
patient participants (N=588)
Study centre
Ulm, n (%) 112 (19.05)
London, n (%) 85 (14.46)
Naples, n (%) 101 (17.18)
Debrecen, n (%) 97 (16.49)
Aalborg, n (%) 98 (16.67)
Zurich, n (%) 95 (16.16)
Gender; female, n (%) 307 (52.21)
Age; years, M (SD) 41.69 (10.74)
Married; n (%) 149 (25.38)
Ethnic group; Caucasian; n (%) 552 (94.04)
Years in school; M (SD) 10.43 (1.88)
Living alone; n (%) 231 (39.55)
Paid or self employed; n (%) 110 (18.74)
Receiving state benefits; n (%) 425 (72.40)
Illness duration; years, M (SD) 12.51 (9.27)
Diagnosis
Psychotic disorder, n (%) 269 (45.75)
Mood disorder, n (%) 200 (34.01)
Other, n (%) 119 (20.24)
TAG; M (SD) 7.54 (2.24)
GAF; M (SD) 49.03 (10.96)
STORI-30
(1) Moratorium, n (%) 115 (19.79)
(2) Awareness and Preparation, n (%) 145 (24.96)
(3) Rebuilding and Growth, n (%) 321 (55.25)
Notes: Missing values: N=1 (married, ethnic group, work, benefits), N=4 (living),
N=7 (STORI), N = 11 (school), N=29 (GAF).
Working in mental health services; years, M (SD) 14.99 (9.66)
Number of patients in study; M (SD) 2.76 (4.46)
Notes. Missing values: N = 6 (gender), N=7 (profession), N = 54 (working
outpatient), N = 41 (working mental health).indicating that participants used 32.7% (2.61 - 0.97/5) of
the whole range of the 5-point scale. Skewness of items
averaged at 0.14 (SD = 0.37; range = -0.51 [#4] – 1.05 [#5]),
and kurtosis at -0.48 (SD = 0.64; range = -1.29 [#1] – 0.81
[#7]), respectively. Number of missing values ranged
from 0.17 – 1.87%. Mean discriminative power (cor-
rected item-total correlation) was 0.48 (SD = 0.13), with
item #4 falling below the cut-off of 0.3. Cronbach’s α
ranged between .87 and .89 regardless of the omission
of any item.
For the CDMS-P IN, participants used 15.5% of the scale
range. Skewness was negative for all items (M = -1.35;
SD = 0.29; range = -0.82 [#19] – -1.56 [#18]; kurtosis:
M = 2.00; SD = 1.47; range = -0.35 [#19] – 3.50 [#18]),
and missing values ranged from 0.17 – 0.34%. Cronbach’s α
substantially increased when deleting item #19 which
also showed low CTIC, so this item is deleted from the
sub-scale in subsequent analysis.
Staff version
As also shown in Table 3 (right section), range of all
items of the CDMS-S PD was also quite homogenous
(SD = 0.55 – 1.27). Items with the most extreme difficul-
ties were #1 and #5, indicating that participants used 31.6%
of the 5-point range. Mean skewness of items was -0.10
(SD = 0.50; range = -0.81 [#1] – 1.13 [#5]), and mean
kurtosis was 0.42 (SD = 1.45; range = -0.92 [#2] – 3.38
[#7]). Number of missing values ranged from 0 – 1.58%,
and mean discriminative power was 0.57 (SD = 0.16), with
Table 3 Item characteristics CDMS Patient (N = 588) and Staff (N = 570) versions
Patient version Staff version
Participation in Decision Making (PD) sub-scale Mean (SD) CITC α Mean (SD) CITC α
1 Important decisions.a 1.95 (1.36) 0.524 0.837 2.71 (1.27) 0.767 0.870
2 Comply with clinician’s advice.a 1.58 (1.18) 0.520 0.837 2.20 (1.19) 0.668 0.876
3 Treatment in the clinic.a 1.85 (1.34) 0.552 0.835 2.58 (1.22) 0.695 0.874
4 Every day problems. 2.61 (1.08) 0.140 0.857 2.38 (1.10) 0.302 0.894
5 More control when worsening.a 0.97 (0.98) 0.445 0.842 1.13 (0.94) 0.453 0.885
6 See clinician how often. 2.00 (1.23) 0.413 0.844 1.39 (0.96) 0.341 0.890
7 Return to work. 2.24 (0.89) 0.453 0.842 1.95 (0.60) 0.545 0.882
8 Suitable occupation. 2.46 (0.91) 0.368 0.845 1.92 (0.55) 0.325 0.888
9 Amount of work. 2.42 (0.97) 0.405 0.844 2.04 (0.63) 0.508 0.883
10 See a doctor. 2.40 (1.29) 0.393 0.845 2.17 (0.95) 0.485 0.884
11Dosage of medication. 1.35 (1.06) 0.573 0.835 2.66 (0.73) 0.697 0.876
12 Another medication. 1.28 (1.02) 0.612 0.833 2.68 (0.77) 0.701 0.876
13 Medication at all. 1.53 (1.20) 0.617 0.831 2.60 (0.76) 0.741 0.874
14 Form of medication. 1.83 (1.26) 0.555 0.835 2.18 (0.78) 0.563 0.881
15 Duration of medication. 1.24 (1.04) 0.663 0.830 2.70 (0.78) 0.737 0.874
Information (IN) sub-scale Mean (SD) CITC α Mean (SD) CITC α
16 Informed about the facts. 3.14 (0.94) 0.506 0.660 2.63 (0.89) 0.350 0.717
17 Know exactly. 3.29 (0.86) 0.617 0.630 3.04 (0.74) 0.638 0.631
18 Explain purpose. 3.41 (0.74) 0.623 0.639 3.43 (0.63) 0.550 0.665
19 Information when asked for.a 2.64 (1.23) 0.121 0.807 3.03 (0.91) 0.232 0.753
20 Side effects. 3.23 (0.97) 0.467 0.672 2.55 (0.97) 0.516 0.664
21 Various treatment methods. 3.39 (0.80) 0.587 0.643 3.25 (0.70) 0.565 0.656
Notes: a 5 items reverse coded for analysis; CITC: Corrected Item-Total Correlation; α = α after item deletion; Ns for CITC and α: 573 for PD-P, 583 for IN-P, 555 for
PD-S, and 568 for IN-S.
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discriminability. Consistent with the patient version,
Cronbach’s α ranged between .87 and .89 regardless of the
omission of any item.
For the CDMS-S IN, participants used 17.5% of the
scale range, and skewness was negative for all items
(M = -0.74; SD = 0.33; range = -1.09 [#19] – -0.23 [#20]; kur-
tosis: M = 0.86; SD = 1.04; range = -0.70 [#20] – 1.89 [#18]),
and missing values ranged from 0 – 0.35%. Furthermore, as
in the patient version, Cronbach’s α was highest when dele-
ting item #19 which also showed poor CITC, so this item is
deleted from the sub-scale in subsequent analysis.
Descriptives of all four CDMS subscale scores without
item #19 in both patient and staff versions as well as
Cronbach’s α’s including their confidence intervals are
shown in the upper part of Table 4. As can be seen in
Figure 1,0 for both patient and staff versions, PD scores
are approximately normally distributed which is not the
case for IN scores which are distinctly skewed to the left.
As also shown in Table 4, clinical utility categorical
scores show that the vast majority of both patients and
staff members prefer shared (rather than passive oractive) participation in decision making, while need for
information was mostly high in patients and predomin-
antly moderate in staff.
Stability
Descriptives for CDMS subscales at one-year follow-up are
also shown in Table 4. Distribution of clinical utility categor-
ical scores was similar to baseline data. Paired t-tests showed
that, compared to T0, scores one year later were higher for
IN staff (tdf=489 = -2.59, p = .010), and not different for the
other scales (PD patient: tdf=511 = -1.93, p = .054; IN patient:
tdf=513 = -0.21, p = .830; PD staff: tdf=489 = 0.26, p = .798).
Spearman correlation coefficients between baseline and
one-year follow-up of the four scales ranged between
0.36 and 0.79 (and 0.24 and 0.66 for the clinical utility
categorical scores), and were higher for the PD scales in
than for the IN scales in both patient and staff versions.
Validity
Spearman correlations between PD and IN subscales
were close to 0 for both patients and staff versions
(see Table 5).
Table 4 CDMS subscale scores at baseline and follow-up
Scale Mean (SD) N α (CI 95%) Utility: passive, N (%) shared, N (%) active, N (%)
Baseline PD Patient 1.84 (0.64) 586 0.849 (0.830 - 0.866) 175 (29.86) 319 (54.44) 92 (15.69)
PD Staff 1.83 (0.57) 563 0.888 (0.874 - 0.901) 124 (22.02) 397 (70.51) 42 (7.46)
Utility: low, N (%) moderate, N (%) high, N (%)
IN Patient 3.29 (0.65) 587 0.808 (0.782 - 0.831) 21 (3.58) 207 (35.26) 359 (61.16)
IN Staff 2.98 (0.56) 570 0.753 (0.720 - 0.784) 45 (7.89) 324 (56.84) 201 (35.26)
Scale Mean (SD) N ρtt Utility: passive, N (%) shared, N (%) active, N (%)
1 year PD Patient 1.87 (0.68) 514 ρ=0.69; p<0.001; N=512 152 (29.57) 276 (53.69) 86 (16.73)
Utility*: ρ=0.64; p<0.001
PD Staff 1.84 (0.57) 491 ρ=0.79; p<0.001; N=485 114 (23.22) 337 (68.64) 40 (8.15)
Utility*: ρ=0.66; p<0.001
Utility: low, N (%) moderate, N (%) high, N (%)
IN Patient 3.31 (0.55) 515 ρ=0.36; p<.001; N=514 12 (2.33) 213 (41.36) 290 (56.31)
Utility*: ρ=0.24; p<0.001
IN Staff 3.05 (0.57) 495 ρ=0.44; p<0.001; N=490 27 (5.45) 270 (54.55) 198 (40.00)
Utility*: ρ=0.31; p<.001
Notes: CI = confidence interval; Utility: Clinical utility categorical data; * = Ns as previous line.
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http://www.biomedcentral.com/1471-244X/13/48As also shown in Table 5, correlations were moderate
for PD with the CDIS involvement item in both patients
and staff. Correlation of IN with the CDIS information
item was also moderate in patients, but the two variables
were hardly related in the staff version. Finally, analysis
of concurrent validity showed that CDMS-P PD was un-
related to recovery, while CDMS-P IN scores increased
with a higher STORI stage (Fdf = 2;577 = 3.54; p = .030;
also see Table 4). Correlations using the clinical utility
categorical scores yielded similar results.Figure 1 Q-Q Plots of patient (above) and staff ratings (below) of CDM
Information (right).Discussion
This paper reports on instrument development and psy-
chometric properties of the Clinical Decision Making
Style Scale (CDMS) which consists of patient (CDMS-P)
and staff (CDMS-S) versions which are structured iden-
tically with wording changed to reflect the different
perspectives.
Instrument development followed current state-of-the-
art recommendations to ensure consistently high stan-
dards across study sites in preparing the source versionS subscales Participation in Decision Making (left) and
Table 5 Relations among CDMS subscales and convergent
validity (Spearman)
Scale IN CDIS involvement CDIS information STORI
Continuous
PD Patient ρ=0.01 ρ=-0.27 ρ=0.04
p=0.837 p<0.001 p=0.319
N=586 N=445 N=580
PD Staff ρ=0.14 ρ=-0.43
p=0.001 p<0.001
N=563 N=417
IN Patient ρ=0.31 ρ=0.12
p<.001 p=.003
N=446 N=580
IN Staff ρ=0.27
p<0.001
N=422
Utility*
PD Patient ρ=0.06 ρ=-0.26 ρ=0.07
p=0.181 p<0.001 p=0.093
PD Staff ρ=0.08 ρ=-0.39
p=0.051 p<0.001
IN Patient ρ=0.26 ρ=0.11
p<0.001 p=0.008
IN Staff ρ=0.18
p<0.001
Notes: *Ns as above.
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http://www.biomedcentral.com/1471-244X/13/48and the final versions in five languages. Throughout this
process, special efforts were made to use a participatory
approach, i.e. expert advice from patients and staff was
systematically sought from the start, in order to generate
an instrument which is feasible and meaningful to its
users. High face validity and completion rates of no less
than 98% on any CDMS item indicate that this process
has been successful.
Item analysis showed that items of the PD subscale
were approximately normally distributed and that parti-
cipants used a large portion of the 5-point scale. In con-
trast, the items in the IN subscale were distinctly left
skewed and consequently also participants’ use of the
scale range was rather restricted. Item-level findings
were consistent with the total scores, which for the PD
subscale in both patients and staff showed approximate
normal distribution, while both IN subscale totals were
distinctly left skewed. This pattern is in line with Giersdorf
and colleagues [50] who also reported that IN items
showed little variance and a ceiling effect in 646 people
with different chronic conditions. In line with Ende and
colleagues [28], this indicates that patients have a strong
interest in being well informed. Additionally it shows thatmental health professionals acknowledge a high need for
information among service users.
Furthermore, categorising the subscale totals accord-
ing to clinical utility criteria showed that both patients
and staff members preferred shared (rather than passive
or active) participation in decision making, while need
for information was high from the patient perspective
and moderate from the staff perspective.
Reliability
Reliability indices were satisfactory to excellent for all
items in the PD subscale. This was also the case in both
patient and staff versions of the IN subscale, apart from
one item (#19) which showed low discriminatory power
and contributed negatively to internal consistency in
both patient and staff versions of the IN subscale. After
deletion of this item, internal consistency (Cronbach’s
α’s) including the lower bounds of the 95% confidence
intervals were at least adequate, and mainly good. These
findings are in line with previous research on the API
which has also identified some items with poor reliability
[33] and reported similarly good internal consistency
[28,32] in people with various conditions. However, in a
study with people with schizophrenia [29], the API’s in-
ternal consistency was poor(α = 0.57), justifying the
efforts made during the CDMS development process to
modify and maximise its meaningfulness for people with
severe mental illness.
Stability over one year was high for PD in both
patients and staff, and moderate for IN. Overall, this
finding shows that, as intended, the CDMS measures a
relatively constant trait-like component of clinical deci-
sion making.
Validity
PD and IN subscales did not correlate. This indicates
convergent validity and shows that, as in the original
API, preferences for participation in decision making are
independent of preferences for information. This study
adds that this is also the case in people with severe men-
tal illness and in mental health professionals. Further-
more, convergent validity could be established for the
PD subscale for both patient and staff versions, and for
the IN subscale for the patient version. However, corre-
lations with the corresponding CDIS items were only
moderate, and the IN subscale did not correlate with the
corresponding CDIS information item. When interpret-
ing these finding on convergent validity, it should be
borne in mind that CDMS taps into general aspects of
decision making style, while CDIS rates involvement and
information relating to a specific decision making en-
counter. Finally, concurrent validity was demonstrated
for the CDMS-P IN by showing that the patient-rated
need for information increased with a higher stage of
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related to recovery. Thus, concurrent validity could only
partially be demonstrated. This finding raises the ques-
tion about the relationship between recovery and partici-
pation in decision making.
Analysis on all indices of reliability and validity for the
categorised clinical utility categories yielded results simi-
lar to the analysis of the continuous CDMS variables.
This finding indicates the adequacy of the chosen cut-off
points.Limitations
This study has several limitations. First, test-retest reli-
ability in the strict sense, with participants filling in the
scale again shortly after initial completion has not been
examined. Test-retest reliability should be tested for
shorter intervals. Second, evaluation of validity was
made difficult because clinical decision-making style is a
specific concept, making identification of comparator
scales problematic. Third, there are weaknesses in sam-
ple generalizability. In the instrument development, con-
venience samples were chosen as participants of the
focus group. Thus, the samples may not truly reflect the
mentally ill population. The same issue arises for staff
participants in focus groups. Fourth, a pilot phase be-
tween instrument development and administration of
the instruments in the CEDAR study would have been
worthwhile. Finally, future studies might consider sam-
pling other populations containing native speakers of the
five languages.Conclusion
This study investigated the psychometric properties of
the Clinical Decision Making Style (CDMS) scale which
measures general and specific preferences for decision
making (subscale Participation in Decision Making - PD)
as well as preferences regarding the provision of infor-
mation to the patient (subscale Information - IN) from
the perspectives of people with severe mental illness
(CDMS –P) and mental health professionals (CDMS –S).
The subscales reliably measured distinct characteristics
of decision making, which showed relative stability over
time. Validity was demonstrated to some extent and
needs further investigation. Overall, the psychometric
properties of the CDMS are satisfactory making it pos-
sible to further examine the relation between clinical de-
cision making and outcome in the treatment of people
with severe mental illness across Europe.
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